Pharmaceutical Business review

Inverness Medical closes public offering

The total number of shares sold by the company included 1.8 million shares sold to the underwriters upon their exercise of their over-allotment option in full. Certain selling stockholders of the company also sold 165,698 shares of common stock in the offering.

UBS Investment Bank, Jefferies & Company and Merrill Lynch & Co. are acting as joint book-running managers for the offering. Leerink Swann and Stifel, Nicolaus & Company are acting as co-managers for the offering.